Transgene SA TRGNF
Set alert
0.80 USD +0.06 +7.38%
At close · Oct 30
0.80 Day range 0.80
0.70 52-week range 1.08
- YTD
- -20.00%
- 1 year
- +14.29%
- Open
- 0.80
- Prev close
- 0.745
- Mkt cap
- 222.60M
- Vol
- 1.00K
- Avg vol
- 26
- EPS
- -0.20
- P/E
- 0.00
More statistics
- Low
- 0.80
- High
- 0.80
2Y chart
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| RSI: Oversold | Apr 28, 2026 | 6 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bullish | Dec 2, 2025 | 11 months ago |
| RSI: Overbought | Dec 2, 2025 | 11 months ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
News
- Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC Transcript
- Transgene SA (TRGNF) Q4 2025 Earnings Call Transcript
- Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
- Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
- Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
- Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript
- Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
- Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
- Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
- Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
Your note
Sign in to keep a note on TRGNF — it syncs with the Stock Master app.